Follow The Filings

NVAX Novavax

Novavax earnings company data as of 3:35 PM ET 11/17

  • 1 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS -0.34 -0.19 Beat
Rev $54.2M — —

Insider trades

Open-market buys and sales by NVAX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NVAX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales

No open-market buys or sales on file.

Also filed in the last 12 months, not counted as buying or selling: 21 option exercises and 13 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 7.01,8.01,9.01
SCHEDULE 13D/A —
SCHEDULE 13G —
SCHEDULE 13G —
10-Q
8-K 2.02,9.01
8-K 5.07
SCHEDULE 13D/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
DEF 14A
SCHEDULE 13G/A —
DEFA14A
SCHEDULE 13D/A —
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf